The Caris Precision Oncology Alliance has brought together academic institutions and community practices with the goal of performing research and exchanging evidence and ideas for new types of tests, said W. Michael Korn, MD.
The Caris Precision Oncology Alliance has brought together academic institutions and community practices with the goal of performing research and exchanging evidence and ideas for new types of tests, said W. Michael Korn, MD, professor of medicine in the Division of Hematology/Oncology at the University of California, San Francisco, and chief medical officer of Caris Life Sciences.
Transcript
What is the purpose of the Caris Precision Oncology Alliance? How do members collaborate?
There is actually some overlap with what QCCA [Quality Cancer Care Alliance] is doing, and I think it's an extremely important initiative. So, what this is a now pretty large group of mostly academic institutions that are affiliated with Caris Life Sciences—in terms of being affiliated with a goal of performing research together, with the goal of exchanging evidence on how to interpret our findings, and exchange ideas and express needs for new types of tests.
So, there are now over 40 institutions all across the United States, including, I believe, currently 11 NCI [National Cancer Institute]–designated Comprehensive Cancer Centers. So, there's a lot of intellectual power now coming together. It's a very dynamic organization, and we perform many, many research projects in collaboration with these institutions. And it's really has been tremendously beneficial for both sides.
There are also some more community-oriented institutions [that are a] part of that. And I think that's where the overlap really exists. For there are, you know, institutions that have affiliated practices in their surrounding. And so, I think there's a real overlap, and we recognize that understanding what's happening in kind of an oncologist’s practices, not academic [medical centers], is extremely important, because that's the vast majority of [where] patients are being treated.
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More